Nanosonics Limited (ASX:NAN)

Australia flag Australia · Delayed Price · Currency is AUD
3.500
-0.180 (-4.89%)
Apr 28, 2026, 4:10 PM AEST
-23.75%
Market Cap 1.05B
Revenue (ttm) 207.26M
Net Income (ttm) 20.56M
Shares Out 299.23M
EPS (ttm) 0.07
PE Ratio 52.63
Forward PE 54.95
Dividend n/a
Ex-Dividend Date n/a
Volume 470,466
Average Volume 733,270
Open 3.630
Previous Close 3.680
Day's Range 3.480 - 3.650
52-Week Range 3.210 - 5.080
Beta 1.30
RSI 44.84
Earnings Date Feb 23, 2026

About Nanosonics

Nanosonics Limited operates as an infection prevention company in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. The company manufactures and distributes trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. It also provides trophon2 a device with an enhanced design and new functionality, including AcuTrace TM for audit-ready digital record-keeping and capabi... [Read more]

Sector Healthcare
Founded 2000
Employees 470
Stock Exchange Australian Securities Exchange
Ticker Symbol NAN
Full Company Profile

Financial Performance

In fiscal year 2025, Nanosonics's revenue was 198.63 million, an increase of 16.83% compared to the previous year's 170.01 million. Earnings were 20.68 million, an increase of 59.39%.

Financial Statements

News

There is no news available yet.